Further research focusing on Thrombospondin 1, PEDF and other anti-angiogenic factors could prove useful for developing a more integrative understanding of BPD and ROP pathogenesis and contribute to uniform clinical approaches in order to more physiologically balance vessel development and vessel stabilization. This evidence concerns the gene SERPINF1 and bronchopulmonary dysplasia.